Anne Arnett, Ph.D.

 

Dr. Anne Arnett was a 2020-2022 Klingenstein Third Generation Foundation (KTGF) Child and Adolescent ADHD Fellow for her project, “Stability of Neurophysiological Biomarkers of ADHD.” Her project used scalp electrophysiology (EEG) and event related potentials (ERP) to identify reliable biomarkers of ADHD to facilitate earlier diagnoses in children. At the time of her Fellowship, Dr. Arnett was an Assistant Professor of Psychiatry and Behavioral Sciences at the University of Washington.   

Currently, Dr. Arnett is a Scientist in the Division of Developmental Medicine and a Wade Family Investigator in Child Psychology at Boston Children’s Hospital. Dr. Arnett is also an Assistant Professor of Pediatrics at Harvard Medical School. Dr. Arnett currently directs the Arnett Lab, one of Boston Children Hospital’s Laboratories of Cognitive Neuroscience. The Arnett Lab aims to improve precision medicine care for children and families affected by neurodevelopmental disorders by investigating brain-behavior associations leading to atypical neurodevelopment among children. Currently funded research initiatives include an investigation of rare genetic variants associated with ADHD in families; with her colleagues, Dr. Arnett has discovered that up to 50% of individuals with ADHD have a change in their DNA that affects protein expression. Another federally funded study follows 500 children from infancy through 4 years of age to identify brain, developmental and environmental contributions to ADHD and disruptive behaviors in preschoolers. The Arnett Lab is also testing novel interventions aimed at preventing substance use in adolescents with ADHD and decreasing problematic screen use in school-age children and families with ADHD.  

Dr. Arnett received a Ph.D. in Clinical Psychology from the University of Denver and completed her postdoctoral training at the University of Washington.